Clinical significance of the differentiation between Mycobacterium avium and Mycobacterium intracellulare in M avium complex lung disease

Chest

Volumn 142, Issue 6, 2012, Pages 1482-1488

  Koh, Won Jung ^a   Jeong, Byeong Ho ^a   Jeon, Kyeongman ^a   Lee, Nam Yong ^a   Lee, Kyung Soo ^a   Woo, Sook Young ^b   Shin, Sung Jae ^c   Kwon, O Jung ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Yonsei University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CLARITHROMYCIN; ETHAMBUTOL; RIFAMPICIN; STREPTOMYCIN;

ADULT; AGE; AGED; ANTIBIOTIC THERAPY; ARTICLE; ATYPICAL MYCOBACTERIOSIS; BODY MASS; CLINICAL FEATURE; CONTROLLED STUDY; COUGHING; DIFFERENTIAL DIAGNOSIS; DRUG DOSE REDUCTION; DRUG RESPONSE; FEMALE; HIGH RESOLUTION COMPUTER TOMOGRAPHY; HUMAN; LUNG INFECTION; LUNG RESECTION; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIUM AVIUM LUNG DISEASE; MYCOBACTERIUM INTRACELLULARE AVIUM LUNG DISEASE; MYCOBACTERIUM INTRACELLULARE LUNG DISEASE; PRIORITY JOURNAL; PROGNOSIS; SPUTUM SMEAR; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 84866438316     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-0494     Document Type: Article

References (33)

1. Griffith DE, Aksamit T, Brown-Elliott BA, et alATS Mycobacterial Diseases Subcommittee;American Thoracic Society; Infectious Disease Society of America. An official ATS/IDSA statement: diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases [published correction in Am J Respir Crit Care Med. 2007;175(7):744-745]. Am J Respir Crit Care Med. 2007;175(4):367-416. (Pubitemid 46271561)
2. Kasperbauer SH, Daley CL. Diagnosis and treatment of infections due to Mycobacterium avium complex. Semin Respir Crit Care Med. 2008;29(5):569-576.
3. Field SK, Fisher D, Cowie RL. Mycobacterium avium complex pulmonary disease in patients without HIV infection. Chest. 2004;126(2):566-581. (Pubitemid 39093445)
4. Lam PK, Griffith DE, Aksamit TR, et al. Factors related to response to intermittent treatment of Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2006;173(11):1283-1289. (Pubitemid 43848401)
5. Griffith DE, Brown-Elliott BA, Langsjoen B, et al. Clinical and molecular analysis of macrolide resistance in Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2006;174(8):928-934. (Pubitemid 44564794)
6. Kitada S, Kobayashi K, Ichiyama S, et al MAC Serodiagnosis Study Group. Serodiagnosis of Mycobacterium avium-complex pulmonary disease using an enzyme immunoassay kit. Am J Respir Crit Care Med. 2008;177(7):793-797. (Pubitemid 351490567)
7. Daley CL, Griffith DE. Pulmonary non-tuberculous mycobacterial infections. Int J Tuberc Lung Dis. 2010;14(6):665-671.
8. Yamazaki Y, Kubo K, Takamizawa A, Yamamoto H, Honda T, Sone S. Markers indicating deterioration of pulmonary Mycobacterium avium-intracellulare infection. Am J Respir Crit Care Med. 1999;160(6):1851-1855. (Pubitemid 30004686)
9. Yamori S, Tsukamura M. Comparison of prognosis of pulmonary diseases caused by Mycobacterium avium and by Mycobacterium intracellulare. Chest. 1992;102(1):89-90.
10. Maesaki S, Kohno S, Koga H, Miyazaki Y, Kaku M. A clinical comparison between Mycobacterium avium and Mycobacterium intracellulare infections. Chest. 1993;104(5):1408-1411. (Pubitemid 23327853)
11. Han XY, Tarrand JJ, Infante R, Jacobson KL, Truong M. Clinical significance and epidemiologic analyses of Mycobacterium avium and Mycobacterium intracellulare among patients without AIDS. J Clin Microbiol. 2005;43(9):4407-4412. (Pubitemid 41298220)
12. Koh WJ, Kwon OJ, Jeon K, et al. Clinical significance of nontuberculous mycobacteria isolated from respiratory specimens in Korea. Chest. 2006;129(2):341-348. (Pubitemid 43289853)
13. Ryoo SW, Shin S, Shim MS, et al. Spread of nontuberculous mycobacteria from 1993 to 2006 in Koreans. J Clin Lab Anal. 2008;22(6):415-420.
14. Park YS, Lee CH, Lee SM, et al. Rapid increase of nontuberculous mycobacterial lung diseases at a tertiary referral hospital in South Korea. Int J Tuberc Lung Dis. 2010;14(8):1069-1071.
15. Sim YS, Park HY, Jeon K, Suh GY, Kwon OJ, Koh WJ. Standardized combination antibiotic treatment of Mycobacterium avium complex lung disease. Yonsei Med J. 2010;51(6):888-894.
16. National Institutes of Health Clinical Center. Study of nontuberculous mycobaterial lung disease. NCT00970801. Clinical Trials.gov. Bethesda, MD: National Institutes of Health;2009. Updated February 21, 2012.
17. Lee H, Park HJ, Cho SN, Bai GH, Kim SJ. Species identifi cation of mycobacteria by PCR-restriction fragment length polymorphism of the rpoB gene. J Clin Microbiol. 2000;38(8):2966-2971. (Pubitemid 30640582)
18. Chung MJ, Lee KS, Koh WJ, et al. Thin-section CT findings of nontuberculous mycobacterial pulmonary diseases: comparison between Mycobacterium avium-intracellulare complex and Mycobacterium abscessus infection. J Korean Med Sci. 2005;20(5):777-783.
19. Koh WJ, Yu CM, Suh GY, et al. Pulmonary TB and NTM lung disease: comparison of characteristics in patients with AFB smear-positive sputum. Int J Tuberc Lung Dis. 2006;10(9):1001-1007. (Pubitemid 44378976)
20. Kikuchi T, Watanabe A, Gomi K, et al. Association between mycobacterial genotypes and disease progression in Mycobacterium avium pulmonary infection. Thorax. 2009;64(10):901-907.
21. Marras TK, Chedore P, Ying AM, Jamieson F. Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003. Thorax. 2007;62(8):661-666. (Pubitemid 47235003)
22. van Ingen J, Bendien SA, de Lange WC, et al. Clinical relevance of non-tuberculous mycobacteria isolated in the Nijmegen-Arnhem region, The Netherlands. Thorax. 2009;64(6):502-506.
23. Thomson RM;NTM working group at Queensland TB Control Centre and Queensland Mycobacterial Reference Laboratory. Changing epidemiology of pulmonary nontuberculous mycobacteria infections. Emerg Infect Dis. 2010;16(10):1576-1583.
24. Prevots DR, Shaw PA, Strickland D, et al. Nontuberculous mycobacterial lung disease prevalence at four integrated health care delivery systems. Am J Respir Crit Care Med. 2010;182(7):970-976.
25. Winthrop KL, McNelley E, Kendall B, et al. Pulmonary nontuberculous mycobacterial disease prevalence and clinical features: an emerging public health disease. Am J Respir Crit Care Med. 2010;182(7):977-982.
26. Simons S, van Ingen J, Hsueh PR, et al. Nontuberculous mycobacteria in respiratory tract infections, eastern Asia. Emerg Infect Dis. 2011;17(3):343-349.
27. Guthertz LS, Damsker B, Bottone EJ, Ford EG, Midura TF, Janda JM. Mycobacterium avium and Mycobacterium intracellulare infections in patients with and without AIDS. J Infect Dis. 1989;160(6):1037-1041.
28. Tomioka H, Saito H, Sato K, Dawson DJ. Comparison of the virulence for mice of Mycobacterium avium and Mycobacterium intracellulare identified by DNA probe test. Microbiol Immunol. 1993;37(4):259-264.
29. Leber A, Marras TK. The cost of medical management of pulmonary nontuberculous mycobacterial disease in Ontario, Canada. Eur Respir J. 2011;37(5):1158-1165.
30. Smole SC, McAleese F, Ngampasutadol J, Von Reyn CF, Arbeit RD. Clinical and epidemiological correlates of genotypes within the Mycobacterium avium complex defined by restriction and sequence analysis of hsp65. J Clin Microbiol. 2002;40(9):3374-3380.
31. Prammananan T, Phunpruch S, Tingtoy N, Srimuang S, Chaiprasert A. Distribution of hsp65 PCR-restriction enzyme analysis patterns among Mycobacterium avium complex isolates in Thailand. J Clin Microbiol. 2006;44(10):3819-3821.
32. Hayashi M, Takayanagi N, Kanauchi T, Miyahara Y, Yanagisawa T, Sugita Y. Prognostic factors of 634 HIV-negative patients with Mycobacterium avium complex lung disease. Am J Respir Crit Care Med. 2012;185(5):575-583.
33. Ito Y, Hirai T, Maekawa K, et al. Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease. Int J Tuberc Lung Dis. 2012;16(3):408-414.